None listed
Conditions
Interventions
Intervention1: Oral Midazolam: Injection iv/im midazolam liquid mixed with glucose in dose of 0.5mg/kg.
Intervention2: Intranasal Midazolam: Intranasal Midazolam in form of spray given in dose of 0.2m
Sponsors
Dr. Rajal Udaybhai Dave
Eligibility
Inclusion criteria
Inclusion criteria: 1 Children aged 4 to 10 years 2 ASA 1 score & Frankl behavior rating 2 3 Need to undergo dental procedure like pulpectomy under local anesthesia 4 In whom non pharmacological behavior technique have not been successful
Exclusion criteria
Exclusion criteria: 1 Who would not be cleared by anesthetist for sedation 2 Any known allergy or hypersensitivity reaction to the drugs being used 3 Who would be given any analgesics 6 hours before the procedure 4 Who would be recently administered drugs like erythromycin, clarithromycin, fluconazole or anticonvulsants which interfere with pharmacokinetics of midazolam 5 Any known case of any type of systemic medical illness like breathing difficulties, cognitive impairment, etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oral and intranasal midazolam are expected to provide similar anxiolysis and sedation in children, though oral administration may show better acceptance. Oral midazolam and nitrous oxide are anticipated to have comparable clinical success in reducing anxiety. Intranasal midazolam may be as effective as nitrous oxide and serve as an alternative when mask tolerance is poor.Timepoint: At baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Rajal Udaybhai Dave
Department of Pediatric and Preventive Dentistry,Government Dental College And Hospital, Ahmedabad
Outcome results
None listed